EGFR and cancer: EGFR T790M mutation and mesenchymal-epithelial transition (MET) amplification have been demonstrated to be genetic causes of acquired resistance to TKI7, 8, However, genetic cause of intrinsic resistance to TKI in kinase-driven cancer patients remains unknown.